MEDAC PHARMA LLP
Significant control: Nicholas Mohr (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Medac Pharma LLP sell?
We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
MEDAC PHARMA LLP is an active private limited company (company number OC415849) incorporated on 9 February 2017, registered in London. Accounts are on file at Companies House (full) but not yet parsed into this record.
Ownership and control
- Nicholas Mohr
- voting rights 50 to 75 percent limited liability partnership
- right to share surplus assets 50 to 75 percent limited liability partnership
- Nicolas Mohr
- voting rights 50 to 75 percent limited liability partnership
- right to share surplus assets 50 to 75 percent limited liability partnership
- Medac Gesellschaft Fur Klinische Spezialpraparate Mbh
- voting rights 75 to 100 percent limited liability partnership
- right to share surplus assets 75 to 100 percent limited liability partnership
- Mr Michael Anthony Johnson
- significant influence or control limited liability partnership
- significant influence or control as trust limited liability partnership
- significant influence or control as firm limited liability partnership
- Miss Hannah Teather
- significant influence or control limited liability partnership
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 9 February 20179 yrs ago
- First accounts due
- 9 November 20182905 days overdue
- Confirmation statement due
- 23 February 2027in 123 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC None Supplied
- None Supplied
- Accounts type
- Full
Financials
Accounts exist on the register but their figures are not in this dataset yet.
Filing and accounts signals
- Incorporated five or more years agoIncorporated 9 February 2017
- Accounts past their due dateDue 9 November 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 123 days
- First accounts due2905 days overdue
- Incorporated
Reminders for MEDAC PHARMA LLP
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.